COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection
- PMID: 32761166
- DOI: 10.1001/jama.2020.13170
COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection
Comment in
-
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.Travel Med Infect Dis. 2021 Mar-Apr;40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31. Travel Med Infect Dis. 2021. PMID: 33535106 Free PMC article. No abstract available.
Similar articles
-
Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.Am J Trop Med Hyg. 2021 Mar 15;104(5):1611-1612. doi: 10.4269/ajtmh.20-1085. Am J Trop Med Hyg. 2021. PMID: 33720844 Free PMC article.
-
Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.Travel Med Infect Dis. 2021 Mar-Apr;40:101981. doi: 10.1016/j.tmaid.2021.101981. Epub 2021 Jan 31. Travel Med Infect Dis. 2021. PMID: 33535106 Free PMC article. No abstract available.
-
Prevention of Strongyloides stercoralis hyperinfection in leprosy patients on long-term steroid therapy.Indian J Dermatol Venereol Leprol. 2018 Nov-Dec;84(6):709-711. doi: 10.4103/ijdvl.IJDVL_574_17. Indian J Dermatol Venereol Leprol. 2018. PMID: 30207326 No abstract available.
-
Strongyloidiasis in transplant patients.Clin Infect Dis. 2009 Nov 1;49(9):1411-23. doi: 10.1086/630201. Clin Infect Dis. 2009. PMID: 19807271 Free PMC article. Review.
-
Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view.Eur J Intern Med. 2009 Dec;20(8):744-8. doi: 10.1016/j.ejim.2009.09.001. Epub 2009 Sep 27. Eur J Intern Med. 2009. PMID: 19892301 Review.
Cited by
-
Strongyloides stercoralis infection in the UK: A systematic review and meta-analysis of published cases.Clin Med (Lond). 2024 Jul;24(4):100227. doi: 10.1016/j.clinme.2024.100227. Epub 2024 Jul 14. Clin Med (Lond). 2024. PMID: 39009349 Free PMC article. Review.
-
What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia.Front Med (Lausanne). 2023 Nov 14;10:1253135. doi: 10.3389/fmed.2023.1253135. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034537 Free PMC article.
-
Strongyloides hyperinfection syndrome precipitated by immunosuppressive therapy for rheumatoid arthritis and COVID-19 pneumonia.Trop Dis Travel Med Vaccines. 2023 Oct 5;9(1):15. doi: 10.1186/s40794-023-00201-0. Trop Dis Travel Med Vaccines. 2023. PMID: 37794447 Free PMC article.
-
Strongyloides stercoralis Hyperinfection Syndrome in Pregnancy.Cureus. 2023 Aug 16;15(8):e43568. doi: 10.7759/cureus.43568. eCollection 2023 Aug. Cureus. 2023. PMID: 37719554 Free PMC article.
-
Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia.Oman Med J. 2023 Jul 31;38(4):e534. doi: 10.5001/omj.2023.31. eCollection 2023 Jul. Oman Med J. 2023. PMID: 37593525 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
